Zimmer Biomet Holdings SG&A decreased by 2.6% to $849.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.0%, from $758.80M to $849.90M. Over 4 years (FY 2021 to FY 2025), SG&A shows an upward trend with a 3.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
A rising ratio of SG&A to revenue may indicate inefficiency or aggressive expansion, while a falling ratio suggests improved operating leverage.
Detailed definition
Selling, general, and administrative expenses encompass the costs associated with the day-to-day operation of the busine...
Peer comparison
Standard operating expense category; peers with larger global sales forces typically show higher absolute SG&A levels.
selling_general_and_administrativeHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $696.80M | $684.40M | $805.20M | $684.50M | $695.20M | $654.90M | $727.10M | $715.90M | $725.80M | $674.90M | $722.30M | $736.20M | $737.10M | $709.70M | $746.90M | $758.80M | $814.80M | $811.40M | $872.30M | $849.90M |
| QoQ Change | — | -1.8% | +17.7% | -15.0% | +1.6% | -5.8% | +11.0% | -1.5% | +1.4% | -7.0% | +7.0% | +1.9% | +0.1% | -3.7% | +5.2% | +1.6% | +7.4% | -0.4% | +7.5% | -2.6% |
| YoY Change | — | — | — | — | -0.2% | -4.3% | -9.7% | +4.6% | +4.4% | +3.1% | -0.7% | +2.8% | +1.6% | +5.2% | +3.4% | +3.1% | +10.5% | +14.3% | +16.8% | +12.0% |
Product Breakdown
| Segment | FY'23 | FY'24 |
|---|---|---|
| Shipping And Handling | $272.70M | $288.30M |
| Total | $2.84B | $2.93B |
All segment values are derived from annual filings.
Geographic Breakdown
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Americas | $359.60M | $339.10M | $335.30M | $374.30M | $425.60M |
| EMEA | $123.30M | $136.60M | $132.40M | $144.80M | $149.50M |
| Asia Pacific | $85.10M | $91.00M | $94.60M | $89.20M | $88.00M |
| Total | $758.80M | $814.80M | $811.40M | $872.30M | $849.90M |
SG&A at Other Companies
Frequently Asked Questions
- What is Zimmer Biomet Holdings's sg&a?
- Zimmer Biomet Holdings (ZBH) reported sg&a of $849.90M in Q1 2026.
- How has Zimmer Biomet Holdings's sg&a changed year-over-year?
- Zimmer Biomet Holdings's sg&a increased by 12.0% year-over-year, from $758.80M to $849.90M.
- What is the long-term trend for Zimmer Biomet Holdings's sg&a?
- Over 4 years (2021 to 2025), Zimmer Biomet Holdings's sg&a has grown at a 3.5% compound annual growth rate (CAGR), from $2.84B to $3.26B.
- What does sg&a mean?
- The overhead costs of running the business, including sales, marketing, and general corporate expenses.